Registers› Irish medicines ›H. Lundbeck A/S

Medicines register · Ireland

H. Lundbeck A/S — licensed medicines

16 medicines held by H. Lundbeck A/S on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 09 Oct 2026, 03:22 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Brintellix 10 mg film-coated tablets EU/1/13/891/008-017

Vortioxetine hydrobromide

H. Lundbeck A/S

—

Brintellix 15 mg film-coated tablets EU/1/13/891/018-026

Vortioxetine hydrobromide

H. Lundbeck A/S

—

Brintellix 20 mg film-coated tablets EU/1/13/891/027-035

Vortioxetine hydrobromide

H. Lundbeck A/S

—

Brintellix 20 mg/ml oral drops, solution EU/1/13/891/036

Vortioxetine-dl-lactate

H. Lundbeck A/S

—

Brintellix 5 mg film-coated tablets EU/1/13/891/001-007

Vortioxetine hydrobromide

H. Lundbeck A/S

—

EBIXA 10 mg film-coated tablets EU/1/02/219/001-003

Memantine

H. Lundbeck A/S

—

Ebixa 20 mg film-coated tablets EU/1/02/219/023-035

Memantine hydrochloride

H. Lundbeck A/S

—

Ebixa 5 mg film-coated tabletsEbixa 10 mg film-coated tabletsEbixa 15 mg film-coated tabletsEbixa 20 mg film-coated tablets EU/1/02/219/022

Memantine hydrochloride

H. Lundbeck A/S

—

Ebixa 5 mg/pump actuation oral solution EU/1/02/219/005-006

Memantine hydrochloride

H. Lundbeck A/S

—

Lexapro 10 mg film-coated tablets PA0805/002/002

Escitalopram

H. Lundbeck A/S

Not marketed

Lexapro 15 mg film-coated tablets PA0805/002/003

Escitalopram

H. Lundbeck A/S

Not marketed

Lexapro 20 mg film-coated tablets PA0805/002/004

Escitalopram

H. Lundbeck A/S

Not marketed

Lexapro 5 mg film-coated tablets PA0805/002/001

Escitalopram

H. Lundbeck A/S

Not marketed

Selincro 18 mg film-coated tablets EU/1/12/815/001-005

Nalmefene

H. Lundbeck A/S

—

VYEPTI 100 mg concentrate for solution for infusion EU/1/21/1599/001

Eptinezumab

H. Lundbeck A/S

—

VYEPTI 300 mg concentrate for solution for infusion EU/1/21/1599/003

Eptinezumab

H. Lundbeck A/S

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 9 October 2026. https://priyalifescience.com/medicines/company/h-lundbeck-a-s

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.